|
TCF20 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.072200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.691400E-01 |
| Normal-vs-Stage2 |
3.327600E-01 |
| Normal-vs-Stage3 |
1.458320E-02 |
| Normal-vs-Stage4 |
8.079700E-02 |
| Stage1-vs-Stage2 |
1.781950E-01 |
| Stage1-vs-Stage3 |
1.396050E-03 |
| Stage1-vs-Stage4 |
2.520300E-02 |
| Stage2-vs-Stage3 |
3.293400E-01 |
| Stage2-vs-Stage4 |
6.224400E-01 |
| Stage3-vs-Stage4 |
5.728200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.562800E-01 |
| Normal-vs-AfricanAmerican |
7.491800E-01 |
| Normal-vs-Asian |
3.382200E-01 |
| Caucasian-vs-AfricanAmerican |
6.772200E-01 |
| Caucasian-vs-Asian |
2.573600E-01 |
| AfricanAmerican-vs-Asian |
4.208600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.495170E-01 |
| Normal-vs-Female |
9.239400E-01 |
| Male-vs-Female |
1.217040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.284000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.480600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.553370E-01 |
| Normal-vs-Age(81-100Yrs) |
4.152200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.365000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.479200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.773800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.375050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.584600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.384400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.777900E-02 |
| Normal-vs-Grade 2 |
7.451200E-01 |
| Normal-vs-Grade 3 |
2.000800E-01 |
| Normal-vs-Grade 4 |
2.080200E-02 |
| Grade 1-vs-Grade 2 |
9.159000E-03 |
| Grade 1-vs-Grade 3 |
3.762100E-03 |
| Grade 1-vs-Grade 4 |
3.226400E-04 |
| Grade 2-vs-Grade 3 |
2.489200E-01 |
| Grade 2-vs-Grade 4 |
2.826300E-02 |
| Grade 3-vs-Grade 4 |
2.012800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.388820E-01 |
| Normal-vs-ccB subtype |
1.532070E-02 |
| ccA subtype-vs-ccB subtype |
2.26150000004477E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.650800E-01 |
| Normal-vs-N1 |
3.703200E-01 |
| N0-vs-N1 |
7.665400E-01 |
|
|
